CME Gr Q2 2024 Adj EPS $2.56 Beats $2.54 Estimate, Sales $1.532B Miss $1.534B Estimate
Portfolio Pulse from Benzinga Newsdesk
CME Group (NASDAQ:CME) reported Q2 2024 adjusted EPS of $2.56, beating the estimate of $2.54. However, sales of $1.532 billion missed the estimate of $1.534 billion. Sales increased by 12.68% compared to the same period last year.
July 24, 2024 | 11:01 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CME Group's Q2 2024 earnings per share of $2.56 beat estimates, but sales of $1.532 billion slightly missed expectations. Sales increased by 12.68% year-over-year.
The positive EPS surprise is likely to have a favorable impact on the stock price in the short term, despite the slight miss in sales. The significant year-over-year sales growth also adds a positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100